Michael S Hearne La Jolla Pharmaceutical CO (LJPC) insider trading activity

Michael S Hearne is Chief Financial Officer of LA JOLLA PHARMACEUTICAL CO. Currently has a direct ownership of 0 shares of LJPC, which is worth approximately $0. The most recent transaction as insider was on May 28, 2021, when has been sold 169 shares (Common Stock) at a price of $3.65 per share, resulting in proceeds of $617. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Michael S Hearne Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 28 2021	BUY Grant, award, or other acquisition	$617 $3.65 p/Share	169 Added 4.12%	3,934 Common Stock
May 14 2021	BUY Grant, award, or other acquisition	$618 $3.2 p/Share	193 Added 4.88%	3,765 Common Stock
Apr 30 2021	BUY Grant, award, or other acquisition	$615 $3.77 p/Share	163 Added 4.36%	3,572 Common Stock
Apr 15 2021	BUY Grant, award, or other acquisition	$614 $3.55 p/Share	173 Added 4.32%	3,835 Common Stock
Mar 31 2021	BUY Grant, award, or other acquisition	$619 $3.6 p/Share	172 Added 4.49%	3,662 Common Stock
Mar 15 2021	BUY Grant, award, or other acquisition	$616 $4.85 p/Share	127 Added 3.51%	3,490 Common Stock
Feb 26 2021	BUY Grant, award, or other acquisition	$619 $4.45 p/Share	139 Added 3.97%	3,363 Common Stock
Feb 12 2021	BUY Grant, award, or other acquisition	$3,049 $5.7 p/Share	535 Added 14.23%	3,224 Common Stock
Jan 29 2021	BUY Grant, award, or other acquisition	$614 $5.2 p/Share	118 Added 4.2%	2,689 Common Stock
Jan 15 2021	BUY Grant, award, or other acquisition	$619 $4.55 p/Share	136 Added 11.06%	1,094 Common Stock
Dec 31 2020	BUY Grant, award, or other acquisition	$564 $3.3 p/Share	171 Added 15.15%	958 Common Stock
Dec 15 2020	BUY Grant, award, or other acquisition	$563 $3.83 p/Share	147 Added 15.74%	787 Common Stock
Nov 30 2020	BUY Grant, award, or other acquisition	$565 $4.22 p/Share	134 Added 17.31%	640 Common Stock
Nov 13 2020	BUY Grant, award, or other acquisition	$561 $3.98 p/Share	141 Added 21.79%	506 Common Stock
Oct 30 2020	BUY Grant, award, or other acquisition	$566 $2.89 p/Share	196 Added 34.94%	365 Common Stock
Oct 15 2020	BUY Grant, award, or other acquisition	$561 $3.32 p/Share	169 Added 50.0%	169 Common Stock

Also insider at

ODTC

Odonate Therapeutics, Inc. Financial Services

Chief Financial Officer

MSH

Michael S Hearne

Chief Financial Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LJPC shares.

Notify only if

Value

Insider Trading

Get notified when an La Jolla Pharmaceutical CO insider buys or sells LJPC shares.

Notify only if

Operation

Value

Type

News

Receive news related to LA JOLLA PHARMACEUTICAL CO

Track Activities on LJPC

Account